Polyrizon Competitors and Similar CompaniesClear all
FibroGen's competitors and similar companies include Corcept Therapeutics.
 FibroGen FibroGen is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical needs. |  Corcept Therapeutics Corcept Therapeutics is a company that specializes in the research and development of cortisol modulators. | |
Founding Date | Founding Date 1993 | Founding Date 1998 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Francisco, US HQ | Locations Redwood City, US HQ |
Employees | Employees 53115% increase | Employees 50042% increase |
Valuation ($) | Valuation ($) 30.7 m | Valuation ($) 5 b |
Financial | ||
Revenue (est.) | Revenue (est.) $6.4m (FY, 2025) | Revenue (est.) $761.4m (FY, 2025) |
Cost of goods | Cost of goods $556k (FY, 2025) | Cost of goods $13m (FY, 2025) |
Gross profit | Gross profit $5.9m (FY, 2025) | Gross profit $748.4m (FY, 2025) |
Net income | Net income $183.5m (FY, 2025) | Net income $99.7m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Corcept Therapeutics
HQ
Redwood City, US
Employees
500↑ 42% increase
Corcept Therapeutics is a company that specializes in the research and development of cortisol modulators.
View company